FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077912 [Registered on: 10/12/2024] Trial Registered Prospectively
Last Modified On: 20/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Psychotherapeutic]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to evaluate the effectiveness of Brief Interpersonal Psychotherapy in reducing suicidal ideation and attempts among youth with suicide attempts  
Scientific Title of Study   Effectiveness and Feasibility of Brief Interpersonal Psychotherapy (B-IPT) among youth with suicide attempts: A Randomized Controlled Study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dhanpati Sahu 
Designation  PhD Scholar 
Affiliation  RIMS, Ranchi 
Address  Department of Psychiatry, RIMS, Ranchi
Pin-834009, Jharkhand
Ranchi
JHARKHAND
834009
India 
Phone  9006728762  
Fax    
Email  dhanusahu95@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dhanpati Sahu 
Designation  PhD Scholar 
Affiliation  RIMS, Ranchi 
Address  Department of Psychiatry, RIMS, Ranchi
Pin-834009, Jharkhand
Ranchi
JHARKHAND
834009
India 
Phone  9006728762  
Fax    
Email  dhanusahu95@gmail.com  
 
Details of Contact Person
Public Query  
Name  Dr Ajay Kumar Bakhla 
Designation  Professor and HOD of Psychiatry 
Affiliation  RIMS, Ranchi 
Address  Department of Psychiatry, Rajendra Institute of Medical Sciences (RIMS), Ranchi Pin-834009, Jharkhand
Department of Psychiatry, RIMS, Ranchi Pin-834009, Jharkhand
Ranchi
JHARKHAND
834009
India 
Phone  9835193088  
Fax    
Email  ajaybakhla@gmail.com  
 
Source of Monetary or Material Support  
Rajendra Institute of Medical Sciences, Ranchi, Pin-834009, State-Jharkhand, India 
 
Primary Sponsor  
Name  Dhanpati Sahu 
Address  Principal investigators/PhD scholar, Department of Psychiatry, RIMS Ranchi, PIN-834009, Jharkhand, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajay Kumar Bakhla  Rajendra Institute of Medical Sciences (RIMS), Ranchi  Room no.Nil, Child Guidance Clinic, OPD Psychiatry, Department of Psychiatry
Ranchi
JHARKHAND 		 9835193088

ajaybakhla@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee RIMS Ranchi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F320||Major depressive disorder, singleepisode, mild, (2) ICD-10 Condition: F321||Major depressive disorder, singleepisode, moderate, (3) ICD-10 Condition: F322||Major depressive disorder, singleepisode, severe without psychotic features, (4) ICD-10 Condition: F324||Major depressive disorder, singleepisode, in partial remission, (5) ICD-10 Condition: F325||Major depressive disorder, singleepisode, in full remission, (6) ICD-10 Condition: F328||Other depressive episodes, (7) ICD-10 Condition: F329||Major depressive disorder, singleepisode, unspecified, (8) ICD-10 Condition: F330||Major depressive disorder, recurrent, mild, (9) ICD-10 Condition: F331||Major depressive disorder, recurrent, moderate, (10) ICD-10 Condition: F332||Major depressive disorder, recurrent severe without psychotic features, (11) ICD-10 Condition: F334||Major depressive disorder, recurrent, in remission, (12) ICD-10 Condition: F338||Other recurrent depressive disorders, (13) ICD-10 Condition: F339||Major depressive disorder, recurrent, unspecified, (14) ICD-10 Condition: F340||Cyclothymic disorder, (15) ICD-10 Condition: F341||Dysthymic disorder, (16) ICD-10 Condition: F348||Other persistent mood [affective]disorders, (17) ICD-10 Condition: F349||Persistent mood [affective] disorder, unspecified, (18) ICD-10 Condition: F39||Unspecified mood [affective] disorder, (19) ICD-10 Condition: F313||Bipolar disorder, current episodedepressed, mild or moderate severity, (20) ICD-10 Condition: F314||Bipolar disorder, current episodedepressed, severe, without psychotic features, (21) ICD-10 Condition: F317||Bipolar disorder, currently in remission, (22) ICD-10 Condition: F316||Bipolar disorder, current episodemixed, (23) ICD-10 Condition: F101||Alcohol abuse, (24) ICD-10 Condition: F102||Alcohol dependence, (25) ICD-10 Condition: F109||Alcohol use, unspecified, (26) ICD-10 Condition: F111||Opioid abuse, (27) ICD-10 Condition: F112||Opioid dependence, (28) ICD-10 Condition: F119||Opioid use, unspecified, (29) ICD-10 Condition: F121||Cannabis abuse, (30) ICD-10 Condition: F122||Cannabis dependence, (31) ICD-10 Condition: F129||Cannabis use, unspecified, (32) ICD-10 Condition: F131||Sedative, hypnotic or anxiolytic-related abuse, (33) ICD-10 Condition: F139||Sedative, hypnotic or anxiolytic-related use, unspecified, (34) ICD-10 Condition: F141||Cocaine abuse, (35) ICD-10 Condition: F149||Cocaine use, unspecified, (36) ICD-10 Condition: F151||Other stimulant abuse, (37) ICD-10 Condition: F152||Other stimulant dependence, (38) ICD-10 Condition: F159||Other stimulant use, unspecified, (39) ICD-10 Condition: F172||Nicotine dependence, (40) ICD-10 Condition: F181||Inhalant abuse, (41) ICD-10 Condition: F182||Inhalant dependence, (42) ICD-10 Condition: F189||Inhalant use, unspecified, (43) ICD-10 Condition: F191||Other psychoactive substance abuse, (44) ICD-10 Condition: F192||Other psychoactive substance dependence, (45) ICD-10 Condition: F199||Other psychoactive substance use,unspecified, (46) ICD-10 Condition: F400||Agoraphobia, (47) ICD-10 Condition: F401||Social phobias, (48) ICD-10 Condition: F402||Specific (isolated) phobias, (49) ICD-10 Condition: F408||Other phobic anxiety disorders, (50) ICD-10 Condition: F409||Phobic anxiety disorder, unspecified, (51) ICD-10 Condition: F410||Panic disorder [episodic paroxysmal anxiety], (52) ICD-10 Condition: F411||Generalized anxiety disorder, (53) ICD-10 Condition: F413||Other mixed anxiety disorders, (54) ICD-10 Condition: F418||Other specified anxiety disorders, (55) ICD-10 Condition: F419||Anxiety disorder, unspecified, (56) ICD-10 Condition: F422||Mixed obsessional thoughts and acts, (57) ICD-10 Condition: F423||Hoarding disorder, (58) ICD-10 Condition: F424||Excoriation (skin-picking) disorder, (59) ICD-10 Condition: F428||Other obsessive-compulsive disorder, (60) ICD-10 Condition: F429||Obsessive-compulsive disorder, unspecified, (61) ICD-10 Condition: F430||Acute stress reaction, (62) ICD-10 Condition: F431||Post-traumatic stress disorder (PTSD), (63) ICD-10 Condition: F432||Adjustment disorders, (64) ICD-10 Condition: F438||Other reactions to severe stress, (65) ICD-10 Condition: F439||Reaction to severe stress, unspecified, (66) ICD-10 Condition: F440||Dissociative amnesia, (67) ICD-10 Condition: F442||Dissociative stupor, (68) ICD-10 Condition: F444||Conversion disorder with motor symptom or deficit, (69) ICD-10 Condition: F445||Conversion disorder with seizuresor convulsions, (70) ICD-10 Condition: F446||Conversion disorder with sensory symptom or deficit, (71) ICD-10 Condition: F447||Conversion disorder with mixed symptom presentation, (72) ICD-10 Condition: F448||Other dissociative and conversiondisorders, (73) ICD-10 Condition: F449||Dissociative and conversion disorder, unspecified, (74) ICD-10 Condition: F450||Somatization disorder, (75) ICD-10 Condition: F451||Undifferentiated somatoform disorder, (76) ICD-10 Condition: F452||Hypochondriacal disorders, (77) ICD-10 Condition: F454||Pain disorders related to psychological factors, (78) ICD-10 Condition: F458||Other somatoform disorders, (79) ICD-10 Condition: F459||Somatoform disorder, unspecified, (80) ICD-10 Condition: F481||Depersonalization-derealization syndrome, (81) ICD-10 Condition: F482||Pseudobulbar affect, (82) ICD-10 Condition: F488||Other specified nonpsychotic mental disorders, (83) ICD-10 Condition: F489||Nonpsychotic mental disorder, unspecified, (84) ICD-10 Condition: F500||Anorexia nervosa, (85) ICD-10 Condition: F510||Insomnia not due to a substance orknown physiological condition, (86) ICD-10 Condition: F520||Hypoactive sexual desire disorder, (87) ICD-10 Condition: F521||Sexual aversion disorder, (88) ICD-10 Condition: F522||Sexual arousal disorders, (89) ICD-10 Condition: F523||Orgasmic disorder, (90) ICD-10 Condition: F54||Psychological and behavioral factors associated with disorders or diseases classified elsewhere, (91) ICD-10 Condition: F550||Abuse of antacids, (92) ICD-10 Condition: F551||Abuse of herbal or folk remedies, (93) ICD-10 Condition: F552||Abuse of laxatives, (94) ICD-10 Condition: F553||Abuse of steroids or hormones, (95) ICD-10 Condition: F554||Abuse of vitamins, (96) ICD-10 Condition: F558||Abuse of other non-psychoactive substances, (97) ICD-10 Condition: F59||Unspecified behavioral syndromes associated with physiological disturbances and physical factors, (98) ICD-10 Condition: F600||Paranoid personality disorder, (99) ICD-10 Condition: F601||Schizoid personality disorder, (100) ICD-10 Condition: F602||Antisocial personality disorder, (101) ICD-10 Condition: F603||Borderline personality disorder, (102) ICD-10 Condition: F604||Histrionic personality disorder, (103) ICD-10 Condition: F605||Obsessive-compulsive personality disorder, (104) ICD-10 Condition: F606||Avoidant personality disorder, (105) ICD-10 Condition: F607||Dependent personality disorder, (106) ICD-10 Condition: F608||Other specific personality disorders, (107) ICD-10 Condition: F609||Personality disorder, unspecified, (108) ICD-10 Condition: F630||Pathological gambling, (109) ICD-10 Condition: F631||Pyromania, (110) ICD-10 Condition: F632||Kleptomania, (111) ICD-10 Condition: F633||Trichotillomania, (112) ICD-10 Condition: F638||Other impulse disorders, (113) ICD-10 Condition: F69||Unspecified disorder of adult personality and behavior, (114) ICD-10 Condition: F640||Transsexualism, (115) ICD-10 Condition: F641||Dual role transvestism, (116) ICD-10 Condition: F648||Other gender identity disorders, (117) ICD-10 Condition: F649||Gender identity disorder, unspecified, (118) ICD-10 Condition: F650||Fetishism, (119) ICD-10 Condition: F651||Transvestic fetishism, (120) ICD-10 Condition: F652||Exhibitionism, (121) ICD-10 Condition: F653||Voyeurism, (122) ICD-10 Condition: F654||Pedophilia, (123) ICD-10 Condition: F655||Sadomasochism, (124) ICD-10 Condition: F658||Other paraphilias, (125) ICD-10 Condition: F659||Paraphilia, unspecified, (126) ICD-10 Condition: F66||Other sexual disorders, (127) ICD-10 Condition: F681||Factitious disorder, (128) ICD-10 Condition: F688||Other specified disorders of adultpersonality and behavior, (129) ICD-10 Condition: F69||Unspecified disorder of adult personality and behavior, (130) ICD-10 Condition: F910||Conduct disorder confined to family context, (131) ICD-10 Condition: F912||Conduct disorder, adolescent-onsettype, (132) ICD-10 Condition: F913||Oppositional defiant disorder, (133) ICD-10 Condition: F918||Other conduct disorders, (134) ICD-10 Condition: F919||Conduct disorder, unspecified, (135) ICD-10 Condition: F985||Adult onset fluency disorder, (136) ICD-10 Condition: F988||Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence, (137) ICD-10 Condition: F989||Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence, (138) ICD-10 Condition: F900||Attention-deficit hyperactivity disorder, predominantly inattentive type, (139) ICD-10 Condition: F901||Attention-deficit hyperactivity disorder, predominantly hyperactive type, (140) ICD-10 Condition: F902||Attention-deficit hyperactivity disorder, combined type, (141) ICD-10 Condition: F908||Attention-deficit hyperactivity disorder, other type, (142) ICD-10 Condition: F909||Attention-deficit hyperactivity disorder, unspecified type, (143) ICD-10 Condition: F99||Mental disorder, not otherwise specified, (144) ICD-10 Condition: F88||Other disorders of psychological development, (145) ICD-10 Condition: F89||Unspecified disorder of psychological development,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Brief Interpersonal Psychotherapy  This module will be Ultra Brief Crisis Interpersonal Psychotherapy (UBC-IPT), a session once a week for up to 5 weeks. Each session will last 60 minutes. In IPT, 4 interpersonal issues are identified: grief and loss, interpersonal disputes, and role transitions are the primary focus of treatment. This therapy will be conducted after training in IPT with respective IPT therapists/clinicians with necessary modifications per patients’ needs. It will be adapted upon request from Klomek et al., 2021. The first and last sessions will be face-to-face, and the middle session will be an audio conference. The experimental group can also access medication and the Telemanas facility. The total duration of the intervention will be 5 hours in five session. 
Comparator Agent  Enhance usual care  Enhanced usual care (EUC): Due to participants with high risk, controlled group participants with suicide attempts will be engaged in brief counselling and medication as per patients needs. The duration of brief counselling will be a maximum of 60 minutes during the study period. that may be divided into 5-10 minutes of counselling every week by audio conference to maintain blinding. Brief Counselling will be provided to the patient and their family, in which the researcher will help the participants find available alternative options, meaning or importance in life. The degree of enhancement can range from minimal to extensive, such as each participant will be well-communicated about his/her future risk behaviours or intrusive thoughts of suicidal intent, and they can call TeleMANAS anytime (24/7). 
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  29.00 Year(s)
Gender  Both 
Details  (A) Inclusion Criteria for Experimental Group
1. Patients with a suicide attempt(s)
2. Patients who will attend emergency service at RIMS, Ranchi
3. Age ranges between 15-29 years
4. Patients and their caregivers who will give written informed consent.
5. Participants who will be able to comprehend Hindi and English.
6. Participants who will receive enhanced usual care plus brief interpersonal psychotherapy

(B) Inclusion Criteria for Control Group

1. Patients with a suicide attempt(s)
2. Patients who will attend emergency service at RIMS, Ranchi
3. Age ranges between 15-29 years
4. Patients and their caregivers who will give written informed consent.
5. Participants who will be able to comprehend Hindi and English.
6. Participants who will receive enhanced usual care only

 
 
ExclusionCriteria 
Details  (C)Exclusion Criteria
1. Patients who will be illiterate.
2. Patients who will have a significant history of delirium, seizure disorders, psychotic symptoms, intellectual disability and any surgical complications
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effectiveness of brief interpersonal psychotherapy on suicidal ideation and attempts in comparison to enhanced usual care in participants with suicide attempts at the end of five sessions of intervention.  one month 
 
Secondary Outcome  
Outcome  TimePoints 
• To evaluate the effectiveness of brief interpersonal psychotherapy on symptoms of depression in comparison to enhanced usual care in participants with suicide attempts at the end of sessions of intervention.  one month 
• To evaluate the effectiveness of brief interpersonal psychotherapy on symptoms of anxiety in comparison to enhanced usual care in participants with suicide attempts at the end of five sessions of intervention.  one month 
 
Target Sample Size   Total Sample Size="84"
Sample Size from India="84" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  		 Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Informed Consent Form
    Response (Others) -  Participant information sheet
  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dhanusahu95@gmail.com].

  6. For how long will this data be available start date provided 03-06-2026 and end date provided 03-12-2027?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   Many bodies of research concluded that individuals with suicide attempts suffer from depressive symptoms and suicidal ideations after usual care and follow-up. The findings of many studies indicated that interpersonal psychotherapy (IPT) has given promising results in managing and preventing many mental health problems, such as depression and suicidal ideations. There was a substantial lack of effectiveness of IPT among individuals with suicide attempts with proper reporting of results with effect size and 95% CI with significant or without significant p-value. So in this study, the researcher will focus on evaluating the effectiveness of IPT on suicidal ideation, attempts, and associated depressive and anxiety symptoms among youth with suicide attempts compared to enhanced usual care adopting a brief therapeutic approach. 
Close